Showing results (71-80 of 443) with videos related to

Sort By:
Pageof 45
Expert Opinion on Biological Therapy|February 27, 2020
Antibody-based therapies for idiopathic pulmonary fibrosisGiacomo Sgalla, Mariachiara Flore, Matteo Siciliano, et al.
Clinics in Chest Medicine|February 28, 2012
Management of idiopathic pulmonary fibrosisStefania Cerri, Paolo Spagnolo, Fabrizio Luppi, et al.
Expert Opinion on Investigational Drugs|January 24, 2023
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF)Giacomo Sgalla, Jacopo Simonetti, Stefania Cortese, et al.
Expert Opinion on Emerging Drugs|November 13, 2023
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyondCarmelo Sofia, Alessia Comes, Giacomo Sgalla, et al.
European Journal of Heart Failure|August 8, 2018
Treating heart failure with preserved ejection fraction: learning from pulmonary fibrosisFrancesca Graziani, Francesco Varone, Filippo Crea, et al.
Expert Opinion on Investigational Drugs|May 26, 2020
Pamrevlumab for the treatment of idiopathic pulmonary fibrosisGiacomo Sgalla, Claudia Franciosa, Jacopo Simonetti, et al.
Expert Opinion on Investigational Drugs|February 1, 2024
Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosisJacopo Simonetti, Marco Ficili, Giacomo Sgalla, et al.
Respiratory Medicine|November 29, 2012
Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosisJoyce S Lee, Eunice J Kim, Kara L Lynch, et al.
The European Respiratory Journal|April 23, 2015
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trialsHarold R Collard, Williamson Z Bradford, Vincent Cottin, et al.
Expert Opinion on Pharmacotherapy|December 15, 2021
Advances with pharmacotherapy for the treatment of interstitial lung diseaseAlessia Comes, Giacomo Sgalla, Alessandro Perrotta, et al.
Pageof 45